Why do women with melanoma do better than men?

por Smalley, Keiran SM
Publicado 2018

Using quantitative proteomic analysis to understand genotype specific intrinsic drug resistance in melanoma

por Koomen, John M., Smalley, Keiran S. M.
Publicado 2011

Inhibition of BRAF and BRAF+MEK drives a metastatic switch in melanoma

por Smalley, Keiran SM, Fedorenko, Inna V
Publicado 2015

Histone deacetylase inhibitors: a promising partner for MEK inhibitors in uveal melanoma?

por Faião-Flores, Fernanda, Smalley, Keiran SM
Publicado 2019

The complexity of microenvironment-mediated drug resistance

por Fedorenko, Inna V., Smalley, Keiran S.M.
Publicado 2015

23. RETROSPECTIVE REVIEW OF ADULT PATIENTS WITH LEPTOMENINGEAL DISEASE SECONDARY TO MELANOMA AT MOFFITT CANCER CENTER: DIAGNOSIS, TREATMENT AND OUTCOMES

por Pina, Yolanda, Evernden, Brittany, Smalley, Keiran, Forsyth, Peter
Publicado 2020

SinCHet: a MATLAB toolbox for single cell heterogeneity analysis in cancer

por Li, Jiannong, Smalley, Inna, Schell, Michael J, Smalley, Keiran S M, Chen, Y Ann
Publicado 2017

In Vivo Acute Toxicity Studies of Novel Anti-Melanoma Compounds Downregulators of hnRNPH1/H2

por Velayutham, Sadeeshkumar, Seal, Trisha, Danthurthy, Samaya, Zaias, Julia, Smalley, Keiran S. M., Minond, Dmitriy
Publicado 2023

Acral melanoma: new insights into the immune and genomic landscape

por Carvalho, Larissa Anastacio DaCosta, Aguiar, Flavia C., Smalley, Keiran S.M., Possik, Patricia A.
Publicado 2023

BRAF inhibition generates a host/tumor niche that mediates therapeutic escape

por Fedorenko, Inna V., Wargo, Jennifer A., Flaherty, Keith T., Messina, Jane L., Smalley, Keiran S.M.
Publicado 2015

Using personalized medicine in gliomas: a genomic approach to diagnosis and overcoming treatment resistance in a case with pleomorphic xanthoastrocytoma

por Piña, Yolanda, Fusco, Michael J., Macaulay, Robert J., Walko, Christine M., Peguero, Edwin, Evernden, Brittany R., Smalley, Keiran S., Forsyth, Peter
Publicado 2019

LPTO-03. IN-VITRO & IN-VIVO CULTURE OF PATIENT (PT) DERIVED CSF-CTCs IN LEPTOMENINGEAL DISEASE (LMDz) FROM MELANOMA TO IDENTIFY NOVEL TREATMENT STRATEGIES

por Law, Vincent, Evernden, Brittany, Kenchappa, Rajappa, Puskas, John, Caceres, Gisela, Ryzhova, Elena, Smalley, Inna, Etame, Arnold, Sahebjam, Solmaz, Magliocco, Anthony, Smalley, Keiran, Forsyth, Peter
Publicado 2019

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease

por Law, Vincent, Baldwin, Margi, Ramamoorthi, Ganesan, Kodumudi, Krithika, Tran, Nam, Smalley, Inna, Duckett, Derek, Kalinski, Pawel, Czerniecki, Brian, Smalley, Keiran S. M., Forsyth, Peter A.
Publicado 2021

Dabrafenib inhibits the growth of BRAF‐WT cancers through CDK16 and NEK9 inhibition

por Phadke, Manali, Remsing Rix, Lily L., Smalley, Inna, Bryant, Annamarie T., Luo, Yunting, Lawrence, Harshani R., Schaible, Braydon J., Chen, Yian A., Rix, Uwe, Smalley, Keiran S. M.
Publicado 2017

XL888 limits vemurafenib-induced proliferative skin events by suppressing paradoxical MAPK activation

por Phadke, Manali, Gibney, Geoffrey T., Rich, Carolyn J., Fedorenko, Inna V., Chen, Y. Ann, Kudchadkar, Ragini R., Sondak, Vernon K., Weber, Jeffrey, Messina, Jane L., Smalley, Keiran S. M.
Publicado 2015

Novel Anti-Melanoma Compounds Are Efficacious in A375 Cell Line Xenograft Melanoma Model in Nude Mice

por Velayutham, Sadeeshkumar, Seerattan, Ryan, Sultan, Maab, Seal, Trisha, Danthurthy, Samaya, Chinnappan, Baskaran, Landi, Jessica, Pearl, Kaitlyn, Singh, Aveta, Smalley, Keiran S. M., Zaias, Julia, Choi, Jun Yong, Minond, Dmitriy
Publicado 2023

Drepmel—A Multi-Omics Melanoma Drug Repurposing Resource for Prioritizing Drug Combinations and Understanding Tumor Microenvironment

por Thompson, Zachary J., Teer, Jamie K., Li, Jiannong, Chen, Zhihua, Welsh, Eric A., Zhang, Yonghong, Ayoubi, Noura, Eroglu, Zeynep, Tan, Aik Choon, Smalley, Keiran S. M., Chen, Yian Ann
Publicado 2022

The Anti-Melanoma Activity of Dinaciclib, a Cyclin-Dependent Kinase Inhibitor, Is Dependent on p53 Signaling

por Desai, Brijal M., Villanueva, Jessie, Nguyen, Thierry-Thien K., Lioni, Mercedes, Xiao, Min, Kong, Jun, Krepler, Clemens, Vultur, Adina, Flaherty, Keith T., Nathanson, Katherine L., Smalley, Keiran S. M., Herlyn, Meenhard
Publicado 2013

Metabolomics of primary cutaneous melanoma and matched adjacent extratumoral microenvironment

por Taylor, Nicholas J., Gaynanova, Irina, Eschrich, Steven A., Welsh, Eric A., Garrett, Timothy J., Beecher, Chris, Sharma, Ritin, Koomen, John M., Smalley, Keiran S. M., Messina, Jane L., Kanetsky, Peter A.
Publicado 2020

HDAC11 activity contributes to MEK inhibitor escape in uveal melanoma

por Sriramareddy, Sathya Neelature, Faião-Flores, Fernanda, Emmons, Michael F., Saha, Biswarup, Chellappan, Srikumar, Wyatt, Clayton, Smalley, Inna, Licht, Jonathan D., Durante, Michael A., Harbour, J. William, Smalley, Keiran S.M.
Publicado 2022